Shuttered Abbott Units Ink $160M Deal In FCA Case, DOJ Says
A now-defunct diabetic testing equipment supplier last owned by Abbott Laboratories will cough up $160 million to settle claims that it wrongly paid kickbacks and also charged Medicare for unnecessary equipment,...To view the full article, register now.
Already a subscriber? Click here to view full article